ArriVent BioPharma, Inc.’s AVBP share price has surged by 6.01%, which has investors questioning if this is right time to ...

Sunshine Biopharma, Inc.'s stock rose over 3% on Monday, lifting retail investor sentiment, after the company said its ...

AEON Biopharma named Rob Bancroft as its new chief executive. The Irvine, Calif. biopharmaceutical company, which is working on developing an alternative to Botox, said Monday Bancroft brings ...

The data could help the Enhertu regimen overtake a drug combination that’s been used as the initial treatment for ...

The biopharmaceutical sector saw a notable resurgence in 2024, with initial public offerings (IPOs) soaring 68.4% globally to ...

The Compensation Committee approved the grant to Mr. Bancroft of a non-qualified stock option to purchase 59,034 shares of AEON Class A common stock under AEON's 2025 Employment Inducement Incentive ...

March was a light month across the board for hires news, but the digital and supplier sectors in biopharma saw a spat of ...

Shifts in how diseases are diagnosed and prevented could upend current business models in biopharma, according to new re ...

Former CEO, Marc Forth, to remain as a member of the Company's Board of Directors - IRVINE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. ("AEON” or the "Company”) (NYSE: AEON), a ...

Health and Human Services employees aren’t the only ones out of work. Thousands of private-sector biopharma professionals ...

Novo Nordisk (NYSE: NVO) has filed for U.S. approval of an oral version of its blockbuster weight loss drug Wegovy, the company confirmed to BioPharma Dive. The Danish drugmaker disclosed the ...